申请人:H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
公开号:US20210380558A1
公开(公告)日:2021-12-09
Disclosed are inhibitors for the β-catenin/BCL9 interaction. The inhibitors are selective for β-catenin/BCL9 over β-catenin/cadherin interactions. Methods of using the disclosed compounds to treat cancer are also disclosed.